US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DEFIANCE DAILY TARGET 2X LONG HIMS ETF

24.11

-1.0100-4.02%

Post-market: 24.260.1500+0.62%18:26 EDT

Volume:162.29K

Turnover:3.99M

Market Cap:52.79M

PE:- -

High:25.16

Open:23.95

Low:23.66

Close:25.12

52wk High:391.58

52wk Low:12.38

Shares:2.19M

Float Shares:2.19M

Volume Ratio:0.52

T/O Rate:7.41%

Dividend:1.98

Dividend Rate:8.21%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Hims & Hers Chief Legal Officer Soleil Boughton Disposes of 3,458 Common Shares for $97,961.14

Analysts Have Conflicting Sentiments on These Healthcare Companies: Hims & Hers Health (HIMS) and Oxford BioMedica (OtherOXBDF)

Hims & Hers Health Enters Australia, Marks First Asia-Pacific Market Presence

Hims & Hers Enters Australia in First Asia-Pacific Expansion

Hims & Hers Offers GLP-1 Weight-Loss Drugs, Men's Health Treatments in Australia

How GLP-1 Sales Could Play Out for Hims & Hers

Truist Securities Adjusts Price Target on Hims & Hers Health to $32 From $27, Keeps Hold Rating

MT Newswires Live

Hims & Hers’ weight-loss plans draw penalties by Visa, Bloomberg reports

Hims & Hers (HIMS) Stock Looks Like A Bargain After A 396% Run

Simply Wall St.

Market Chatter: Hims & Hers Health Faces Nearly $75,000 Bill From Card Disputes

MT Newswires Live

Hims & Hers Health (HIMS) Lifts Guidance As Scrutiny Builds, Is The Stock Fully Valued?

Simply Wall St.

Hims & Hers Chief Legal Officer Soleil Boughton Disposes of USD 691,808 in Common Shares

Barclays Sees Hims Sales Growth Amid Near-Term Profit Pressure

Hims & Hers CFO Oluyemi Okupe Sells 64,771 Common Shares Worth $2.2 Million

Hims & Hers Health (HIMS) Is Down 9.9% After FTC And Class Action Privacy Allegations - What's Changed

Simply Wall St.

As Hims Prepares for Peptides Launch, Wall Street Cautious on Prospects This Year

Sector Update: Healthcare

MT Newswires Live

3 Stocks Estimated To Be Undervalued In August 2026

Simply Wall St.

Hims & Hers Health Price Target Raised to $32.00/Share from $30.00 by B of a Securities

Hims & Hers Revenue Upside Tempered by Margin Concerns

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/HIMZ/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"HIMZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIMZ\",,,,,undefined,":{"symbol":"HIMZ","market":"US","secType":"STK","nameCN":"DEFIANCE DAILY TARGET 2X LONG HIMS ETF","latestPrice":24.11,"timestamp":1789070400000,"preClose":25.12,"halted":0,"volume":162289,"hourTrading":{"tag":"盘后","latestPrice":24.26,"preClose":24.11,"latestTime":"18:26 EDT","volume":1563,"amount":37715.894913000004,"timestamp":1789079186034,"change":0.15,"changeRate":0.006221,"amplitude":0.018092},"delay":0,"changeRate":-0.04020700636942681,"floatShares":2189609,"shares":2189609,"eps":0,"marketStatus":"Post-Mkt","change":-1.01,"latestTime":"09-10 18:28:01 EDT","open":23.95,"high":25.16,"low":23.66,"amount":3986549.76339,"amplitude":0.059713,"askPrice":24.43,"askSize":100,"bidPrice":24.09,"bidSize":300,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":25.12,"sharesOutstanding":57385000,"nav":25.54,"aum":55922562.78,"dividendRate":0.082124,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":24.289,"preClose":25.12,"latestTime":"09:27 EDT","volume":12586,"amount":303998.317168,"timestamp":1789046862579,"change":-0.831,"changeRate":-0.033081,"amplitude":0.043424},"postHourTrading":{"tag":"盘后","latestPrice":24.26,"preClose":24.11,"latestTime":"18:26 EDT","volume":1563,"amount":37715.894913000004,"timestamp":1789079186034,"change":0.15,"changeRate":0.006221,"amplitude":0.018092},"volumeRatio":0.518062,"impliedVol":1.3066,"impliedVolPercentile":0.1594},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIMZ\",,,,,undefined,":{"symbol":"HIMZ","floatShares":2189609,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.518062,"shares":2189609,"dividePrice":1.98,"high":25.16,"amplitude":0.059713,"preClose":25.12,"low":23.66,"week52Low":12.3816,"pbRate":"--","week52High":391.58,"institutionHeld":0,"latestPrice":24.11,"committee":0.5,"eps":0,"divideRate":0.082124,"volume":162289,"delay":0,"ttmEps":0,"open":23.95,"prevYearClose":81.06,"prevWeekClose":24.6654,"prevMonthClose":28.37,"prevQuarterClose":48.7861,"fiveDayClose":26.57,"twentyDayClose":31.19,"sixtyDayClose":38.42},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HIMZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-19","symbol":"HIMZ","defaultRemindTime":1773927000000,"type":"split","dateTimestamp":1773892800000,"forFactor":14,"toFactor":1,"ratio":14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HIMZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HIMZ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HIMZ\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664980123","title":"Hims & Hers Chief Legal Officer Soleil Boughton Disposes of 3,458 Common Shares for $97,961.14","url":"https://stock-news.laohu8.com/highlight/detail?id=2664980123","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664980123?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:32","pubTimestamp":1788467558,"startTime":"0","endTime":"0","summary":"Hims & Hers Chief Legal Officer Soleil Boughton disposes of 3,458 common shares for $97,961.14Soleil Boughton, Chief Legal Officer at Hims & Hers Health, sold 3,458 Class A common shares on Sept. 2.Sa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL24pSk7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers Chief Legal Officer Soleil Boughton Disposes of 3,458 Common Shares for $97,961.14","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","HIMS","BK4196","HIMZ","HMYY","HIYY","THNR","HEAL","HIMC","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664890596","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Hims & Hers Health (HIMS) and Oxford BioMedica (OtherOXBDF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664890596","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664890596?lang=en_us&edition=fundamental","pubTime":"2026-09-02 17:10","pubTimestamp":1788340215,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS) and Oxford BioMedica (OX...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-hims-hers-health-hims-and-oxford-biomedica-otheroxbdf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-hims-hers-health-hims-and-oxford-biomedica-otheroxbdf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["THNR","GLAM","BK4139","HIMY","HIYY","HIMC","BK4196","HIMZ","OXBDF","HEAL","HIMS","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000400","title":"Hims & Hers Health Enters Australia, Marks First Asia-Pacific Market Presence","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000400","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000400?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:04","pubTimestamp":1788203057,"startTime":"0","endTime":"0","summary":"BRIEF-Hims & Hers Health Enters Australia, Marks First Asia-Pacific Market PresenceAug 31 (Reuters)-Hims & Hers Health, Inc.HIMS.N:HIMS & HERS HEALTH, - ENTERS AUSTRALIA, MARKS FIRST ASIA-PACIFIC MARKET PRESENCESource text:ID:nBw885XpQaFurther company coverage:HIMS.N","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0B2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","THNR","GLAM","HIMS","HIMC","HMYY","HIYY","BK4196","HEAL","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664200049","title":"Hims & Hers Enters Australia in First Asia-Pacific Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2664200049","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664200049?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:00","pubTimestamp":1788202845,"startTime":"0","endTime":"0","summary":"Hims & Hers enters Australia in first Asia-Pacific expansionHims & Hers expanded into Australia, its first Asia-Pacific market, via the rebrand of Eucalyptus-owned men’s health platform Pilot.Pilot be","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL1qWsnD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","THNR","HIYY","HIMZ","HIMC","HIMS","GLAM","HIMY","HEAL","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664129000","title":"Hims & Hers Offers GLP-1 Weight-Loss Drugs, Men's Health Treatments in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2664129000","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664129000?lang=en_us&edition=fundamental","pubTime":"2026-09-01 02:55","pubTimestamp":1788202500,"startTime":"0","endTime":"0","summary":"Hims & Hers offers GLP-1 weight-loss drugs, men'shealth treatments in AustraliaNEW YORK, Aug 31 (Reuters)-Telehealth company Hims & HersHIMS.Nsaid on Monday it has begun offering branded GLP-1 weight-","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0N5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIYY","BK4196","GLAM","HEAL","HIMY","THNR","HIMS","HMYY","HIMZ","HIMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662750377","title":"How GLP-1 Sales Could Play Out for Hims & Hers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662750377","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662750377?lang=en_us&edition=fundamental","pubTime":"2026-08-26 06:23","pubTimestamp":1787696580,"startTime":"0","endTime":"0","summary":"Hims & Hers Health is retooling its core weight-loss business this year, shifting from sales of compounded GLP-1 drugs to branded versions of the blockbuster medications.A new analysis from Truist Sec","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","GLAM","HIMZ","HEAL","HIYY","HIMS","HIMY","THNR","HIMC","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662208954","title":"Truist Securities Adjusts Price Target on Hims & Hers Health to $32 From $27, Keeps Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2662208954","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662208954?lang=en_us&edition=fundamental","pubTime":"2026-08-25 01:16","pubTimestamp":1787591793,"startTime":"0","endTime":"0","summary":"Hims & Hers Health (HIMS) has an average rating of hold and mean price target of $32.22, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HIMY","BK4196","HIYY","HIMS","HEAL","HIMZ","THNR","HIMC","GLAM","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661272481","title":"Hims & Hers’ weight-loss plans draw penalties by Visa, Bloomberg reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2661272481","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661272481?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:30","pubTimestamp":1787581813,"startTime":"0","endTime":"0","summary":"Hims & Hers (HIMS) has been placed in Visa’s (V) Acquirer Monitoring Program after a surge in weight-loss subscription disputes, adding scrutiny to...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/hims-hers-weight-loss-plans-draw-penalties-by-visa-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/hims-hers-weight-loss-plans-draw-penalties-by-visa-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2506952170.USD","LU0061474960.USD","LU0345774391.USD","LU1069347547.HKD","LU1116320901.HKD","IE00BKDWB100.SGD","LU0048584097.USD","LU0787776722.HKD","LU0823417737.USD","LU1670756490.USD","BK4527","LU1804176565.USD","LU1803068979.SGD","LU0426417589.USD","LU1633808545.USD","LU1935043023.USD","SG9999001424.SGD","THNR","XLF","LU0971096721.USD","LU1267930730.SGD","LU1228905037.USD","SGXZ31699556.SGD","LU0316494557.USD","LU0154236417.USD","LU0444973449.USD","LU0234572021.USD","LU0942090050.USD","LU2764263039.SGD","LU2471134952.CNY","LU2361045086.USD","BK4196","IE0000B7K699.USD","IE00B1XK9C88.USD","BK4585","LU1064131342.USD","IE000BZT7R73.USD","LU1236620750.USD","LU0354030438.USD","LU2265009873.SGD","LU1935042991.SGD","LU1069344957.HKD","LU1043141123.HKD","IE00B1BXHZ80.USD","HIMS","LU2750360641.GBP","LU1712237335.SGD","LU1228905540.USD","LU2023250843.SGD","BK4588","LU0097036916.USD","HMYY","LU2237438978.USD","LU0234570918.USD","SG9999014880.SGD","GB00B4LPDJ14.GBP","IE00BJTD4N35.SGD","LU0417517546.SGD","LU0225283273.USD","BK4581","IE00BQXX3D17.EUR","LU0124676726.USD","LU0823434583.USD","IE000WAW04H5.SGD","LU0690374961.EUR","FDFF","LU0683600562.USD","FNCL","LU0175139822.USD","LU0689626769.HKD","LU0965509283.SGD","IE00BWXC8680.SGD","IE00B19Z9505.USD","LU1670628061.USD","LU1852331112.SGD","LU1935042488.USD","LU1037948541.HKD","LU2125909593.SGD","V","SG9999017495.SGD","LU1691799644.USD","LU1046421795.USD","LU1400636657.SGD","LU0823434740.USD","HIMZ","LU0174119429.USD","SG9999014898.SGD","LU0289961442.SGD","LU0640476718.USD","BK4227","LU0289941410.SGD","LU1202635105.USD","LU2764263203.CNY","LU1435385759.SGD","LU1814569148.SGD","IE00BZ1G4Q59.USD","LU1429558221.USD","LU2750360997.AUD","TRUF","UYG","IE000F7OJYX1.SGD","LU2271345857.HKD","IE00BQXX3C00.GBP","LU1316542783.SGD","LU0965509010.AUD","LU1116320737.USD","LU1989772923.USD","LU2471134523.USD","LU1400636491.USD","GLAM","LU1280957306.USD","LU0157215616.USD","LU0957791311.USD","LU1791710400.SGD","VFH","LU2746668974.SGD","LU1861217088.USD","LU2111349929.HKD","LU1923622614.USD","LU1935042215.USD","LU0310800379.SGD","LU0642271901.SGD","LU1035773651.USD","LU0109391861.USD","LU1823568750.SGD","LU1934455277.USD","LU0006306889.USD","LU2506951958.HKD","LU2746668461.USD","LU0127658192.USD","LU2461242641.AUD","LU2471134796.USD","BK4598","LU2360107671.USD","LU0158827948.USD","BK4534","IE00BJTD4V19.USD","IE000SO60NU8.SGD","LU1934455863.HKD","LU0215105999.USD","LU1974910355.USD","LU1232071149.USD","SG9999000418.SGD","LU2264538146.SGD","LU0861579265.USD","LU0672654240.SGD","LU2242649171.HKD","LU0823421333.USD","LU0823421416.USD","LU1043141396.HKD","LU1670627923.USD","LU0708995401.HKD","SG9999018857.SGD","LU0868494617.USD","LU2361044865.SGD","IPAY","LU2125154935.USD","LU0557290698.USD","LU0994945656.USD","LU2506951875.HKD","LU0545562505.USD","LU0965508806.USD","LU1035775433.USD","BK4106","LU2326559502.SGD","LU1121112475.USD","IXG","LU0256863811.USD","LU2089284900.SGD","LU1236620834.HKD","TFNS","SGXZ81514606.USD","HIMY","HIYY","LU0251132253.USD","LU1363072403.SGD","LU2106854487.HKD","LU0472753341.HKD","LU2433249047.HKD","HIMC","LU0170899867.USD","LU0187121727.USD","LU0957808578.USD","LU1917777945.USD","SGXZ51526630.SGD","LU1988902786.USD","LU2404859741.USD","GB00B4QBRK32.GBP","LU2097829019.USD","LU0289960550.SGD","LU0069063385.USD","LU0528227936.USD","LU0889565833.HKD","LU1935043536.SGD","BK4535","LU2125154778.USD","LU2462591350.SGD","LU0109392836.USD","LU0096362180.USD","LU0353189763.USD","LU0158827781.USD","LU0426412945.USD","LU1642822529.SGD","LU0029864427.USD","LU2125909247.SGD","LU0265550359.USD","LU0342679015.USD","LU2360032135.SGD","HEAL","LU2720916845.USD","LU0390134368.USD","SG9999018865.SGD","IE00B19Z8X17.USD","LU0079474960.USD","LU0348723411.USD","LU1645745479.HKD","LU0690374615.EUR","LU0056508442.USD","LU0256863902.USD","IE00B19Z8W00.USD","LU0354030511.USD","LU0106261372.USD","LU1037948897.HKD","LU1400636574.HKD","LU0265550946.USD","LU0057025933.USD","LU0320765059.SGD","LU0353189680.USD","LU0289739343.SGD","LU0133085943.USD","IYG","LU1267930573.SGD","LU2087625088.SGD","LU2404859667.USD","LU2023251221.USD","LU1791710582.SGD","IE000MB6IJN5.SGD","IE00BKVL7J92.USD","LU1623119135.USD","LU1989772840.SGD","LU0345774631.USD","LU1366333091.USD","LU0476273544.USD","BK4533","LU0708994859.HKD","LU0950375773.USD","SGXZ99366536.SGD","SG9999014914.USD","IE00BQXX3F31.USD","LU1815333072.USD","LU0511384066.AUD","LU1979441026.SGD","LU1934455194.USD","LU1861220207.SGD","LU2764262908.HKD","LU1815336760.USD","LU2471134879.HKD","LU0444971666.USD","LU2028103732.USD","LU2506952097.USD","LATR","LU0965509101.SGD","LU2089283258.USD","SG9999014906.USD","BK4559","LU0128525929.USD","LU0868494708.USD","LU2023250504.SGD","LU2244417387.USD","LU0823417653.USD","LU2361044949.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661217334","title":"Hims & Hers (HIMS) Stock Looks Like A Bargain After A 396% Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2661217334","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661217334?lang=en_us&edition=fundamental","pubTime":"2026-08-23 09:23","pubTimestamp":1787448214,"startTime":"0","endTime":"0","summary":"Hims & Hers Health has delivered a very large 3 year gain for shareholders, yet the latest valuation work suggests the stock still trades at a discount to its estimated intrinsic value. With fresh headlines around AI in healthcare, peptide therapies and regulatory scrutiny, the big question for investors is how much of that story is already in the price.\n\nThe stock has returned about 396% over the past 3 years, which puts a lot of focus on whether the current share price can still be...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-hims-stock-looks-like-a-bargain-after-a-396-run","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-hims-stock-looks-like-a-bargain-after-a-396-run","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HEAL","BK4196","GLAM","THNR","HIMY","HIMS","HIYY","HIMC","HMYY","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661972218","title":"Market Chatter: Hims & Hers Health Faces Nearly $75,000 Bill From Card Disputes","url":"https://stock-news.laohu8.com/highlight/detail?id=2661972218","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661972218?lang=en_us&edition=fundamental","pubTime":"2026-08-22 06:27","pubTimestamp":1787351270,"startTime":"0","endTime":"0","summary":"Hims & Hers Health  was placed on notice by Visa for excessive customer complaints in its weight-loss subscription business, Bloomberg reported Friday, citing internal documents.The company was enrolled in Visa's Acquirer Monitoring Program after a surge in credit card disputes in July, with each dispute carrying an $8 surcharge that will result in a bill of nearly $75,000 in September, the report said, citing the documents.Hims was notified of its placement by payment processor Stripe earlier this month and must bring its dispute rate below 1.5% of transactions for three consecutive months to exit the program, according to the documents, Bloomberg reported.A Hims spokesperson said the company has seen \"a relatively small number of disputed charges\" and has taken steps to address it, adding that its checkout process is clear about membership and medication costs, the report said.Hims & Hers Health did not immediately respond to a request for comment from MT Newswires.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HIYY","HIMC","THNR","HIMZ","GLAM","HIMS","HMYY","BK4196","HIMY","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661595332","title":"Hims & Hers Health (HIMS) Lifts Guidance As Scrutiny Builds, Is The Stock Fully Valued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661595332","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661595332?lang=en_us&edition=fundamental","pubTime":"2026-08-21 09:18","pubTimestamp":1787275129,"startTime":"0","endTime":"0","summary":"Hims & Hers Health (HIMS) is back in the spotlight after reporting strong year over year revenue growth and raising its 2026 sales outlook, even as fresh regulatory and legal actions intensify scrutiny of its telehealth model.\nSee our latest analysis for Hims & Hers Health.\nOver the past year, Hims & Hers Health has combined strong revenue updates, raised 2026 sales guidance and a string of regulatory headlines, with the stock showing a 34.15% 90 day share price return but a 27.52% decline in...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-hims-lifts-guidance-as-scrutiny-builds-is-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-hims-lifts-guidance-as-scrutiny-builds-is-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["THNR","HMYY","BK4196","HIMS","HIMZ","HIYY","HIMY","HEAL","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232124","title":"Hims & Hers Chief Legal Officer Soleil Boughton Disposes of USD 691,808 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232124","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232124?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:30","pubTimestamp":1787257857,"startTime":"0","endTime":"0","summary":"Hims & Hers Chief Legal Officer Soleil Boughton disposes of USD 691,808 in common sharesHims & Hers Health Chief Legal Officer Soleil Boughton sold 25,111 Class A common shares on Aug. 19, 2026.Sale p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDLjmkJy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers Chief Legal Officer Soleil Boughton Disposes of USD 691,808 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","HIMZ","THNR","HIYY","HMYY","HIMY","BK4196","HEAL","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660870392","title":"Barclays Sees Hims Sales Growth Amid Near-Term Profit Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=2660870392","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660870392?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:43","pubTimestamp":1787233396,"startTime":"0","endTime":"0","summary":"BUZZ-Barclays sees Hims sales growth amid near-term profit pressure** Shares of telehealth company Hims & Hers HealthHIMS.Nrise 4% to $32.35 in early trading** Barclays says expects higher revenues at","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL4N44H11Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","HIMY","HMYY","BK4196","HIYY","HIMZ","THNR","HIMS","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660949207","title":"Hims & Hers CFO Oluyemi Okupe Sells 64,771 Common Shares Worth $2.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660949207","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660949207?lang=en_us&edition=fundamental","pubTime":"2026-08-19 05:04","pubTimestamp":1787087089,"startTime":"0","endTime":"0","summary":"Hims & Hers CFO Oluyemi Okupe sells 64,771 common shares worth $2.2 millionHims & Hers Health CFO Oluyemi Okupe cut his stake through sales, tax-withholding disposals, RSU settlements, and an option e","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL83TQwd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers CFO Oluyemi Okupe Sells 64,771 Common Shares Worth $2.2 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HEAL","BK4196","HIMS","HIMZ","HIYY","GLAM","HMYY","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660469407","title":"Hims & Hers Health (HIMS) Is Down 9.9% After FTC And Class Action Privacy Allegations - What's Changed","url":"https://stock-news.laohu8.com/highlight/detail?id=2660469407","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660469407?lang=en_us&edition=fundamental","pubTime":"2026-08-18 17:30","pubTimestamp":1787045414,"startTime":"0","endTime":"0","summary":"Earlier this month, Hims & Hers Health faced intensified legal pressure as the FTC, joined by California and Utah authorities, filed a civil enforcement complaint alleging misleading subscription practices and privacy misrepresentations, which was quickly followed by a consumer class action accusing the company of sharing sensitive health data with advertisers without consent.\nThis legal escalation arrives just days after Hims & Hers reported higher quarterly sales of US$753.21 million but...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-hims-is-down-99-after-ftc-and-class-action","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-hims-is-down-99-after-ftc-and-class-action","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HEAL","HIMY","HMYY","BK4196","HIYY","HIMZ","THNR","HIMS","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659902803","title":"As Hims Prepares for Peptides Launch, Wall Street Cautious on Prospects This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2659902803","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659902803?lang=en_us&edition=fundamental","pubTime":"2026-08-13 02:31","pubTimestamp":1786559490,"startTime":"0","endTime":"0","summary":"As Hims prepares for peptides launch, Wall Street cautious on prospects this yearNEW YORK, Aug 12 (Reuters)-Hims & Hers Health plans to offer some legally available peptides in 2026, but investors and","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N4480V7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","HIMY","HIMS","HEAL","HIMZ","HIYY","BK4196","THNR","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658644912","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2658644912","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658644912?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:15","pubTimestamp":1786468518,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Tuesday afternoon, with the NYSE Healthcare Index shedding 0.6% and the State Street Health Care Select Sector SPDR ETF  decreasing 0.4%.The iShares Biotechnology ETF  rose 0.3%In corporate news, Hims & Hers Health  shares were down 3.8% following its Q2 results. The results were mixed, with upside in its US business from branded GLP-1 strength and a ramp in testosterone offset by disappointing gross margin and weak free cash flow, Morgan Stanley said in a note.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4504","LU2089283258.USD","MS","HIMS","LU0158827948.USD","LU1791710400.SGD","LU2357305700.SGD","BK4127","IBB","XLV","LU1791710582.SGD","LU0557290698.USD","LU1720051108.HKD","LU1732799900.SGD","LU0210528500.USD","LU0390134368.USD","IE00B3S45H60.SGD","LU1074936037.SGD","LU1989772923.USD","THNR","HIMY","LU1244550221.USD","GLAM","IE00BKVL7J92.USD","LU0098860793.USD","KBWB","LU0882574139.USD","LU0971096721.USD","LU2089284900.SGD","LU0225283273.USD","LU0528227936.USD","LU1989772840.SGD","BK4516","HIYY","LU0106261372.USD","XBI","LU0912757837.SGD","HIMZ","LU1668664300.SGD","LU0053666078.USD","LU0158827781.USD","HEAL","BK4588","BK4585","IE00B775SV38.USD","LU0320765646.SGD","LU1064131342.USD","LU1720051017.SGD","LU2133065610.SGD","LU0795875169.SGD","LABU","LU2028103732.USD","LU2111349929.HKD","IAI","LU1363072403.SGD","LU0267386448.USD","LU1548497426.USD","BK4196","LU2347655156.SGD","LU1244550494.USD","LU1162221912.USD","HMYY","LU2264538146.SGD","LU0314104364.USD","LU0106831901.USD","LU0795875086.SGD","LU2271345857.HKD","LU2487616109.SGD","LU2023251221.USD","LU1732800096.USD","IE00BZ1G4Q59.USD","LU1244550577.SGD","LU0234570918.USD","BK4581","BK4534","LU0006306889.USD","LU1988902786.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658446912","title":"3 Stocks Estimated To Be Undervalued In August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2658446912","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658446912?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:08","pubTimestamp":1786468082,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has risen by 2.2%, contributing to a remarkable 21% increase over the past year, with earnings forecasted to grow by 17% annually. In this thriving environment, identifying undervalued stocks can offer potential opportunities for investors looking to capitalize on companies that may be trading below their intrinsic value despite strong market performance.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/4214000-choice1-main-header/1585186691957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4214000-choice1-main-header/1585186691957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/consumer-services/nasdaq-blmn/bloomin-brands/news/3-stocks-estimated-to-be-undervalued-in-august-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/consumer-services/nasdaq-blmn/bloomin-brands/news/3-stocks-estimated-to-be-undervalued-in-august-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CECO","IE00B19Z4B17.USD","KMLI","CCB","ZETA","BK4122","SCHM","J","SNDC","SNDU","SNXX","THNR","HEAL","SYM.AU","ALRS","COWG","TMSL","HAWK","HIYY","BK4548","WDAY","LU1868838027.USD","OPTZ","SNDQ","FCUS","BLMN","MELI","SNDG","ZETX","LU1804176565.USD","SYM","IE00B66KJ199.SGD","SCHA","LU0354030511.USD","ONLN","HMYY","PTF","FSMD","LU0106959298.USD","DISK","BK4581","HIMY","CNAV","BK4566","HIMS","GLAM","SNDK","QQQG","IE00BFMHRM44.USD","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658819912","title":"Hims & Hers Health Price Target Raised to $32.00/Share from $30.00 by B of a Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2658819912","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658819912?lang=en_us&edition=fundamental","pubTime":"2026-08-12 00:59","pubTimestamp":1786467540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HIMS/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HMYY","HIMZ","BK4196","THNR","HIYY","HEAL","HIMS","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658149559","title":"Hims & Hers Revenue Upside Tempered by Margin Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2658149559","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658149559?lang=en_us&edition=fundamental","pubTime":"2026-08-12 00:17","pubTimestamp":1786465020,"startTime":"0","endTime":"0","summary":"12:17 ET -- Hims & Hers Health is showing off an impressive growth trajectory for revenue that's being undercut by profitability concerns, Truist analysts say in a research note. The telehealth company raised its full-year revenue outlook on the back of its international expansion and shift toward branded weight-loss drugs, the analysts say. Most of the raise came from the inclusion of Hims' recent acquisition of Eucalyptus, they say. But investors are still debating whether the company can hit profit targets for the second half of the year, they say. Gross margins dropped in 2Q because selling third-party branded GLP-1s yields lower margins than the company's traditional compounded treatments, the analysts say, reiterating their hold rating on the stock. Shares slip 2.5% to $30.97.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIMZ","GLAM","HIMS","HIYY","HEAL","THNR","HIMY","HMYY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}